Antiproliferative and differentiating effects of polysaccharide fraction from fu-ling (Poria cocos) on human leukemic U937 and HL-60 cells

被引:234
作者
Chen, YY [1 ]
Chang, HM [1 ]
机构
[1] Natl Taiwan Univ, Grad Inst Food Sci & Technol, Taipei 10617, Taiwan
关键词
Fu-Ling; Poria cocos; peripheral blood mononuclear cell; conditioned medium (CM); leukemia; polysaccharide; differentiation;
D O I
10.1016/j.fct.2004.01.018
中图分类号
TS2 [食品工业];
学科分类号
0832 [食品科学与工程];
摘要
Poria cocos (PC), Fu-Ling, is an oriental fungus and has been widely used as a Chinese traditional herbal medicine for centuries. In the present study, a neutral polysaccharide fraction from PC (PC-PS) was isolated by a series of chromatographies and its effects on antiproliferation and differentiation of human leukemic cells, U937 and HL-60, were investigated in vitro. Results showed that the molecular weight of isolated PC-PS was approximately 160 kDa, Lis estimated by gel permeation chromatography. The conditioned medium Prepared with PC-PS (15 mug/ml)-stimulated human blood mononuclear cells for 5 days (PC-PS-MNC-CMS) exhibited a potent activity in suppressing the proliferation of U937 and HL-60 cells by 87.3 and 74.7%, respectively. Furthermore, PC-PS-MNC-CM5 induced about 66.6% of the U937 cells and 49.4% of the HL-60 cells to differentiate into mature monocytes/ macrophages, which also markedly expressed surface antigens of CD11b, CD14, and CD 68. The differentiated U937 and HL-60 cells displayed physiological functions such as respiratory burst and phagocytosis, while PC-PS group and control group showed insignificant effects. Interestingly, the levels of interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha in PC-PS-MNC-CM were about 41 and 10 times, respectively, higher than that of control group. Antibody neutralization tests of the PC-PS-MNC-CM5 revealed that the growth-inhibitory and differentiation-inducing activities were mainly due to the elevated cytokines of IFN-gamma and TNF-alpha. It suggests that PC-PS is a biological response modifier (BRM), instead of a cytotoxic reagent, and may be a potential alternative in leukemia therapy. (C) 2004 Published by Elsevier Ltd.
引用
收藏
页码:759 / 769
页数:11
相关论文
共 36 条
[1]
QUANTITATIVE NITROBLUE TETRAZOLIUM TEST IN CHRONIC GRANULOMATOUS DISEASE [J].
BAEHNER, RL ;
NATHAN, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (18) :971-&
[2]
BLACKWILL FR, 1986, CANCER RES, V46, P3990
[3]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]
INVIVO ANTITUMOR-ACTIVITY OF RECOMBINANT HUMAN AND MURINE TNF, ALONE AND IN COMBINATION WITH MURINE IFN-GAMMA, ON A SYNGENEIC MURINE MELANOMA [J].
BROUCKAERT, PGG ;
LEROUXROELS, GG ;
GUISEZ, Y ;
TAVERNIER, J ;
FIERS, W .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (05) :763-769
[5]
ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[6]
Chaplin MF, 1994, CARBOHYDRATE ANAL
[7]
Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells [J].
Chen, YJ ;
Shiao, MS ;
Lee, SS ;
Wang, SY .
LIFE SCIENCES, 1997, 60 (25) :2349-2359
[8]
PRESENT RESULTS OF THE TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH LOW-DOSE CYTOSINE-ARABINOSIDE - PRELIMINARY-RESULTS OF A COOPERATIVE PROTOCOL (38 PATIENTS) AND REVIEW OF THE LITERATURE [J].
CHOMIENNE, C ;
NAJEAN, Y ;
DEGOS, L ;
THOMAS, G ;
BAUMELOU, E ;
CALVO, F ;
CASASSUS, P ;
CICCONE, F ;
FENAUX, P ;
GRIS, JC ;
GROSBOIS, B ;
GUERCI, O ;
LEPEU, G ;
RAIN, JD ;
ROLOVIC, A ;
TURPIN, F ;
SOUTEYRAND, F .
ACTA HAEMATOLOGICA, 1987, 78 :109-115
[9]
EVALUATION OF BASIC PROCEDURES FOR ADOPTIVE IMMUNOTHERAPY FOR GASTRIC-CANCER [J].
FUJIMOTO, T ;
OMOTE, K ;
MAI, M ;
NATSUUMESAKAI, S .
BIOTHERAPY, 1992, 5 (02) :153-163
[10]
GALLAGHER R, 1979, BLOOD, V54, P713